CIK 0001374690 · Non-accelerated filer<br>Smaller reporting company
Larimar Therapeutics, Inc.
Sign in to watch- Ticker
- LRMR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203857670
- Phone
- 844-511-9056
- Business address
- THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
- Former names
- ZAFGEN, INC., ZAFGEN INC
- 4 Grant or award Chief Development Officer acquired 25,637 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 25,637 shares (grant or award)
- 4 Grant or award President and CEO acquired 100,100 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 37,604 shares (grant or award)
- 4 Open-market buy Director bought 9,375,000 shares at $3.20 ($30,000,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Development Officer acquired 23,306 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 23,306 shares (grant or award)
- 4 Grant or award President and CEO acquired 91,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 34,185 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 14 · 271 filings